Jeff Yass’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
Other funds holding CTMX
KCM
Jeff Yass's CTMX Position: Q3 2026 in Review
Jeff Yass increased its CytomX Therapeutics (CTMX) stake by 1,051% in Q3 2026, buying an estimated $3.18M and bringing the position to 1,043,451 shares worth $2.84M. The position accounts for ﹤0.01% of the portfolio, ranked #5528.
Jeff Yass first reported a position in CTMX in Q4 2015 and has held it in 32 quarters since. The position peaked at $8.79M in Q1 2026. 193 funds tracked by Wall St. Rank hold CTMX as of Q3 2026.
- Jeff Yass held 1,043,451 shares of CytomX Therapeutics worth $2.84M as of Q3 2026.
- Jeff Yass bought 952,778 CytomX Therapeutics shares in Q3 2026, an estimated $3.18M.
- CytomX Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #5528 holding.
- Jeff Yass first reported a position in CytomX Therapeutics in Q4 2015 and has held it in 32 quarters since.
- Jeff Yass's CytomX Therapeutics position peaked at $8.79M in Q1 2026.
- 193 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.